• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下植入式心律转复除颤器在患有器质性心脏病或特发性心室颤动患者中的长期“实际应用”表现。

Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.

作者信息

Frommeyer Gerrit, Dechering Dirk G, Kochhäuser Simon, Bettin Markus, Köbe Julia, Eckardt Lars, Reinke Florian

机构信息

Division of Electrophysiology, Department of Cardiovascular Medicine, University of Münster, Münster, Germany.

出版信息

J Interv Card Electrophysiol. 2016 Nov;47(2):185-188. doi: 10.1007/s10840-016-0143-4. Epub 2016 May 23.

DOI:10.1007/s10840-016-0143-4
PMID:27217031
Abstract

BACKGROUNDS

The totally subcutaneous implantable defibrillator (S-ICD) has been designed as a new alternative to conventional implantable defibrillators. This system is especially attractive for young patients. However, long-term experience is not yet available. To address the question whether the S-ICD system is safe and feasible for young patients with electrical heart disease or idiopathic ventricular fibrillation (VF), the data of a standard of care prospective single center S-ICD registry were evaluated.

METHODS

In the present study, 24 patients (age 34.2 ± 11.5 years) with electrical heart disease or idiopathic VF received an S-ICD for primary (n = 8) or secondary prevention (n = 16). The mean follow-up duration was 29.6 ± 15.1 months.

RESULTS

Ventricular arrhythmias were adequately detected in four patients (17 %). In three patients (13 %) oversensing was noticed and led to at least one inappropriate shock in two patients (8 %). Further adverse events included surgical revision due to a mobile pulse generator as well as explantation of one system and switch to a transvenous ICD system due to several ineffective shocks.

CONCLUSIONS

The results of the present study suggest that S-ICD therapy may be an attractive alternative in young patients with electrical heart disease or idiopathic VF. However, episodes of oversensing as well as ineffective shocks may occur.

摘要

背景

完全皮下植入式除颤器(S-ICD)已被设计为传统植入式除颤器的一种新替代方案。该系统对年轻患者尤其具有吸引力。然而,目前尚无长期经验。为探讨S-ICD系统对于患有电心脏病或特发性室颤(VF)的年轻患者是否安全可行,对一项标准治疗前瞻性单中心S-ICD注册研究的数据进行了评估。

方法

在本研究中,24例患有电心脏病或特发性VF的患者(年龄34.2±11.5岁)接受了S-ICD植入,用于一级预防(n = 8)或二级预防(n = 16)。平均随访时间为29.6±15.1个月。

结果

4例患者(17%)的室性心律失常得到了充分检测。3例患者(13%)出现感知过度,导致2例患者(8%)至少发生1次不适当电击。其他不良事件包括因脉冲发生器移动而进行手术修复,以及1例系统被取出并因多次无效电击而转换为经静脉ICD系统。

结论

本研究结果表明,S-ICD治疗对于患有电心脏病或特发性VF的年轻患者可能是一种有吸引力的替代方案。然而,可能会发生感知过度和无效电击的情况。

相似文献

1
Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.皮下植入式心律转复除颤器在患有器质性心脏病或特发性心室颤动患者中的长期“实际应用”表现。
J Interv Card Electrophysiol. 2016 Nov;47(2):185-188. doi: 10.1007/s10840-016-0143-4. Epub 2016 May 23.
2
Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.肥厚型心肌病患者皮下植入式心律转复除颤器系统的长期随访:单中心经验
Clin Res Cardiol. 2016 Jan;105(1):89-93. doi: 10.1007/s00392-015-0901-9. Epub 2015 Aug 2.
3
Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.青少年和年轻成人中皮下植入式心脏复律除颤器的长期经验
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1499-1506. doi: 10.1016/j.jacep.2017.08.017. Epub 2017 Nov 6.
4
Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.皮下植入式心律转复除颤器(ICD)患者的具体适应证和临床结局-全国多中心注册研究。
Eur J Intern Med. 2018 Feb;48:64-68. doi: 10.1016/j.ejim.2017.09.038. Epub 2017 Oct 1.
5
Long-term single-center experience of defibrillator therapy in children and adolescents.长期单中心经验的心脏除颤器治疗在儿童和青少年。
Int J Cardiol. 2018 Nov 15;271:105-108. doi: 10.1016/j.ijcard.2018.05.130. Epub 2018 Jun 1.
6
First clinical experience of the safety and feasibility of total subcutaneous implantable defibrillator in an Asian population.全皮下植入式除颤器在亚洲人群中的安全性和可行性的首次临床经验。
Europace. 2015 Oct;17 Suppl 2:ii63-8. doi: 10.1093/europace/euv144.
7
The "Pain wave": P‑wave oversensing in subcutaneous ICD.“疼痛波”:皮下植入式心律转复除颤器中的P波过度感知
Herzschrittmacherther Elektrophysiol. 2016 Jun;27(2):151-3. doi: 10.1007/s00399-016-0423-9. Epub 2016 Apr 15.
8
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.肥厚型心肌病患者皮下植入式心律转复除颤器:初步经验
J Am Heart Assoc. 2016 Feb 12;5(2):e002488. doi: 10.1161/JAHA.115.002488.
9
Performance of the entirely subcutaneous ICD in borderline indications.完全皮下植入式 ICD 在边缘适应症中的表现。
Clin Res Cardiol. 2020 Jun;109(6):694-699. doi: 10.1007/s00392-019-01558-z. Epub 2019 Oct 4.
10
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.

引用本文的文献

1
Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry.皮下植入式心律转复除颤器的真实世界疗效与安全性:来自GASP注册研究的见解
Biomedicines. 2025 Jun 20;13(7):1510. doi: 10.3390/biomedicines13071510.
2
Long-Term Follow-Up of the S-ICD: A 10-Years Follow-Up Study of a Large Single Center Cohort.皮下植入式心律转复除颤器的长期随访:一项大型单中心队列的10年随访研究。
Pacing Clin Electrophysiol. 2025 Apr;48(4):443-446. doi: 10.1111/pace.15173. Epub 2025 Mar 13.
3
Systematic Review on S-ICD Lead Extraction.

本文引用的文献

1
Limitations in S-ICD therapy: reasons for system explantation.皮下植入式心律转复除颤器(S-ICD)治疗的局限性:系统移除的原因
Clin Res Cardiol. 2015 Oct;104(10):902-7. doi: 10.1007/s00392-015-0880-x. Epub 2015 Jul 7.
2
Inappropriate shock in a subcutaneous ICD due to interference with a street lantern.皮下植入式心律转复除颤器因受路灯干扰而不适当电击。
Int J Cardiol. 2015 Nov 1;198:6-8. doi: 10.1016/j.ijcard.2015.06.115. Epub 2015 Jul 2.
3
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.皮下植入式心律转复除颤器(ICD)的不适当电击:发生率、预测因素及处理
皮下植入式心律转复除颤器(S-ICD)导线拔除的系统评价
J Clin Med. 2023 May 27;12(11):3710. doi: 10.3390/jcm12113710.
4
Outcome of patients with idiopathic ventricular fibrillation and correlation with ECG markers of early repolarization.特发性室颤患者的预后与心电图早期复极标志物的相关性。
Clin Res Cardiol. 2023 Dec;112(12):1748-1753. doi: 10.1007/s00392-022-02125-9. Epub 2022 Nov 19.
5
Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.来自EFFORTLESS队列的离子通道病患者皮下植入式心脏复律除颤器性能评估及与经静脉植入式心律转复除颤器结局的荟萃分析比较。
Heart Rhythm O2. 2020 Oct 28;1(5):326-335. doi: 10.1016/j.hroo.2020.10.002. eCollection 2020 Dec.
6
[Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].[S-ICD®患者不适当电击/T波过度感知的管理]
Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):122-126. doi: 10.1007/s00399-018-0555-1. Epub 2018 Feb 12.
Int J Cardiol. 2015 Sep 15;195:126-33. doi: 10.1016/j.ijcard.2015.05.135. Epub 2015 May 22.
4
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.完全皮下植入式除颤器的安全性和有效性:IDE 研究和 EFFORTLESS 注册研究的汇总分析 2 年结果。
J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615. doi: 10.1016/j.jacc.2015.02.047.
5
Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: a prospective observational study.心电图早期复极模式在脑卒中患者中的发生率及其对预后的影响:一项前瞻性观察研究。
Clin Res Cardiol. 2015 Aug;104(8):666-71. doi: 10.1007/s00392-015-0831-6. Epub 2015 Feb 25.
6
Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病基因变异的临床解读
Clin Res Cardiol. 2015 Apr;104(4):288-303. doi: 10.1007/s00392-014-0794-z. Epub 2014 Nov 15.
7
ICD therapy for primary prevention of sudden cardiac death after Mustard repair for d-transposition of the great arteries.大动脉转位Mustard修复术后心脏性猝死一级预防的植入式心律转复除颤器治疗
Clin Res Cardiol. 2014 Nov;103(11):894-901. doi: 10.1007/s00392-014-0727-x. Epub 2014 May 29.
8
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.全球完全皮下植入式除颤器的经验:来自EFFORTLESS S-ICD注册研究的早期结果。
Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.
9
The subcutaneous defibrillator: a review of the literature.皮下除颤器:文献回顾。
J Am Coll Cardiol. 2014 Apr 22;63(15):1473-9. doi: 10.1016/j.jacc.2014.01.018. Epub 2014 Feb 12.
10
Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.旨在减少不必要的植入式心脏复律除颤器治疗的编程策略对死亡率的影响:系统评价和荟萃分析。
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20.